Arrangement of $5 Billion Financing for The Chemours Company’s Proposed Separation from DuPont

Cravath represented the initial purchasers, led by Credit Suisse, J.P. Morgan Securities, BofA Merrill Lynch, Barclays, Citigroup and Goldman, Sachs & Co., in connection with the US$2.1 billion and €360 million 144A/Reg. S high‑yield senior debt offering of The Chemours Company related to its proposed separation from E. I. du Pont de Nemours and Company. Cravath also represented Credit Suisse and J.P. Morgan Securities in their third‑party tender offer for US$500 million aggregate principal amount of DuPont bonds and their subsequent debt‑for‑debt exchange with DuPont for Chemours notes. In addition, Cravath represented J.P. Morgan Securities, Credit Suisse, Goldman, Sachs & Co., BofA Merrill Lynch, Citigroup, Barclays, HSBC and RBC, as joint lead arrangers of a credit agreement providing for a seven‑year US$1.5 billion senior secured Term Loan B Facility and a five‑year US$1.0 billion senior secured Revolving Credit Facility. The transactions closed on May 12, 2015.

The Cravath team included partner Craig F. Arcella on corporate matters; partner George E. Zobitz, senior attorney Christopher J. Kelly and associates David J. Kohtz and Katherine M. Stork on banking matters; partner J. Leonard Teti II and associates Ashley N. Elnicki and Peter W. Rogers on tax matters; and partner Matthew Morreale on environmental matters. Nicoleta D. Lupea also worked on corporate matters.